Tolboom T C A, Pieterman E, van der Laan W H, Toes R E M, Huidekoper A L, Nelissen R G H H, Breedveld F C, Huizinga T W J
Department of Rheumatology, Leiden University Medical Centre, The Netherlands.
Ann Rheum Dis. 2002 Nov;61(11):975-80. doi: 10.1136/ard.61.11.975.
Matrix metalloproteinases (MMPs) have a pivotal role in the destruction of cartilage in rheumatoid arthritis (RA), which is mediated by the fibroblast-like synoviocytes (FLS).
To examine the in vitro invasiveness of synoviocytes obtained from inflamed joints of patients with arthritis in relation to the expression of MMP 1-14, 17, 19, cathepsin-K, the tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 by FLS.
FLS were derived from 56 patients (30 with RA, 17 with osteoarthritis (OA), and nine with avascular necrosis (AVN)). Invasive growth of FLS through an artificial matrix (Matrigel) was measured in a transwell system. The number of cells that migrated through the matrix were counted. Proliferation rate was determined by counting the FLS after seven days of culturing. Expression of MMPs, cathepsin-K and TIMPs was investigated with reverse transcriptase-polymerase chain reaction and related to the expression of a household gene, beta-actin.
FLS from RA showed greater invasive growth than FLS from OA and AVN. The median number of cells that grew through the matrix membrane was 4788 for RA, significantly higher than the number for OA, 1875 (p<0.001) and for AVN, 1530 (p=0.014). The median rate of proliferation of RA FLS was 0.27 per day compared with OA 0.22 per day (p= 0.012) and AVN 0.25 per day, but there was no correlation between the rate of proliferation and invasive growth in vitro. FLS from RA and OA that expressed MMP-1, MMP-3, or MMP-10 were significantly more invasive (median number of invasive cells: 3835, 4248, 4990, respectively) than cells that did not express these MMPs (1605, p=0.03; 1970, p=0.004; 2360, p=0.012, respectively). There was also a significant relationship between the expression of MMP-1 and MMP-9 and the diagnosis RA (both p=0.013). The expression levels of mRNA for MMP-1 and MMP-2 correlated with the protein levels produced by the synoviocytes as measured by an enzyme linked immunosorbent assay (ELISA).
FLS of RA invade more aggressively in a Matrigel matrix than OA and AVN FLS; this is not because of a higher rate of proliferation of RA FLS. The significant correlation between the expression of MMP-1, MMP-3, and MMP-10 and invasive growth in a Matrigel transwell system suggests that these MMPs play a part in the invasive growth of FLS obtained from patients with RA.
基质金属蛋白酶(MMPs)在类风湿关节炎(RA)的软骨破坏中起关键作用,这种破坏由成纤维样滑膜细胞(FLS)介导。
研究从关节炎患者炎症关节获取的滑膜细胞的体外侵袭性与FLS中MMP 1 - 14、17、19、组织蛋白酶K、基质金属蛋白酶组织抑制剂TIMP - 1和TIMP - 2表达的关系。
FLS来自56例患者(30例RA患者、17例骨关节炎(OA)患者和9例无血管坏死(AVN)患者)。在Transwell系统中测量FLS通过人工基质(基质胶)的侵袭性生长。计数穿过基质的细胞数量。培养7天后通过计数FLS确定增殖率。用逆转录 - 聚合酶链反应研究MMPs、组织蛋白酶K和TIMPs的表达,并与管家基因β - 肌动蛋白的表达相关联。
RA患者的FLS比OA和AVN患者的FLS表现出更强的侵袭性生长。穿过基质膜生长的细胞中位数,RA为4788,显著高于OA的1875(p<0.001)和AVN的1530(p = 0.014)。RA FLS的增殖中位数率为每天0.27,相比之下OA为每天0.22(p = 0.012),AVN为每天0.25,但体外增殖率与侵袭性生长之间无相关性。表达MMP - 1、MMP - 3或MMP - 10的RA和OA的FLS比未表达这些MMPs的细胞侵袭性显著更强(侵袭细胞中位数分别为:3835、4248、4990)(分别为1605,p = 0.03;1970,p = 0.004;2360,p = 0.012)。MMP - 1和MMP - 9的表达与RA诊断之间也存在显著关系(两者p = 0.013)。通过酶联免疫吸附测定(ELISA)测量,MMP - 1和MMP - 2的mRNA表达水平与滑膜细胞产生的蛋白质水平相关。
RA的FLS在基质胶基质中的侵袭性比OA和AVN的FLS更强;这并非因为RA FLS的增殖率更高。MMP - 1、MMP - 3和MMP - 10的表达与在基质胶Transwell系统中的侵袭性生长之间的显著相关性表明,这些MMPs在RA患者来源的FLS的侵袭性生长中起作用。